http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103816117-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-225 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-225 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 |
| filingDate | 2014-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103816117-B |
| titleOfInvention | A kind of amber cloth examines nanosuspension and preparation method thereof |
| abstract | The present invention relates to a kind of hydrophobic drug amber cloth to examine nanosuspension and preparation method thereof.Amber cloth of the present invention examine nanosuspension nano-composition examined by a certain proportion of amber cloth, surfactant and aqueous phase, the solution for having opalescence formed according to certain ratio.The amber cloth examines nanosuspension cloth containing amber and examines 1 part, 0.1~1000 part of surfactant.The amber cloth is examined nanosuspension and prepared using film aquation method, spray drying technology or grinding technique, nanosuspension is made, particle diameter is 10 200nm.The amber cloth, which examines nanosuspension, makes medicine be easier to be absorbed in vivo, is advantageous to improve the bioavilability of medicine.The amber cloth examines nanosuspension compared with amber cloth examines suspension, and rat vivo biodistribution availability improves 10~44 times, can give full play to its curative effect. |
| priorityDate | 2014-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 54.